Cargando…

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis

Newborn bloodspot screening for cystic fibrosis is a valid public health strategy for populations with a high incidence of this inherited condition. There are a wide variety of approaches to screening and in this paper, we propose that a bioethical framework is required to determine the most appropr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, Rachael E., Frith, Lucy, Ulph, Fiona M., Southern, Kevin W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422997/ https://www.ncbi.nlm.nih.gov/pubmed/33073032 http://dx.doi.org/10.3390/ijns6020040

Ejemplares similares

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study
por: Johnson, Faye, et al.
Publicado: (2019)

Understanding Midwives’ Preferences for Providing Information About Newborn Bloodspot Screening
por: Wright, Stuart James, et al.
Publicado: (2018)

Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results
por: Chudleigh, Jane, et al.
Publicado: (2021)

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
por: Wright, Stuart J., et al.
Publicado: (2015)

Qualitative exploration of health professionals’ experiences of communicating positive newborn bloodspot screening results for nine conditions in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Parental Decision-Making and Acceptance of Newborn Bloodspot Screening: An Exploratory Study
por: Nicholls, Stuart G., et al.
Publicado: (2013)

Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020)

Newborn bloodspot screening in the time of COVID-19
por: Greaves, Ronda F., et al.
Publicado: (2021)

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening
por: Ulph, Fiona, et al.
Publicado: (2015)

Parents’ views on accepting, declining, and expanding newborn bloodspot screening
por: van der Pal, Sylvia M., et al.
Publicado: (2022)

Co-designing Improved Communication of Newborn Bloodspot Screening Results to Parents: Mixed Methods Study
por: Chudleigh, Jane, et al.
Publicado: (2022)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges
por: Parker, Hilda, et al.
Publicado: (2007)

Secondary research uses of residual newborn screening dried bloodspots: a scoping review
por: Rothwell, Erin, et al.
Publicado: (2018)

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
por: Boychuk, Natalie A., et al.
Publicado: (2022)

Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders
por: Jansen, Marleen E., et al.
Publicado: (2021)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards?
por: Avard, Denise, et al.
Publicado: (2006)

Assessing a New Method for Measuring Fetal Exposure to Mercury: Newborn Bloodspots
por: Nelson, Jessica W., et al.
Publicado: (2016)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice
por: Lombardo, Silvia, et al.
Publicado: (2023)

Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand
por: Wilaiwongsathien, Kalyarat, et al.
Publicado: (2023)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
por: van Dijk, Tessa, et al.
Publicado: (2021)

What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders
por: di Gangi, Caroline, et al.
Publicado: (2023)

Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study
por: Schlüter, Daniela K, et al.
Publicado: (2020)

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7
por: Streetly, A, et al.
Publicado: (2009)

Processing of positive newborn screening results: a qualitative exploration of current practice in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Influence of maternal socioeconomic deprivation and living environment on newborn bloodspot 25-hydroxyvitamin D levels
por: Högler, Wolfgang, et al.
Publicado: (2022)

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
por: Sinha, Aditi, et al.
Publicado: (2021)

Preferences for aspects of antenatal and newborn screening: a systematic review
por: Vass, Caroline M., et al.
Publicado: (2019)

Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province
por: Luo, Haiyan, et al.
Publicado: (2022)

Design Bioethics: A Theoretical Framework and Argument for Innovation in Bioethics Research
por: Pavarini, Gabriela, et al.
Publicado: (2021)

Rethinking Strategies for Positive Newborn Screening Result (NBS+) Delivery (ReSPoND): a process evaluation of co-designing interventions to minimise impact on parental emotional well-being and stress
por: Chudleigh, Jane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dgu0k63c79qaekpurpl640m1uo